Published in Mental Health Law Weekly, July 15th, 2006
Amarin will retain its primary listing on NASDAQ and is not seeking any additional capital as part of the listing process. Amarin is already well funded with $33 million in cash as at March 31, 2006. Admission to AIM and IEX is expected to occur in mid July.
Admission to AIM and IEX will enhance Amarin's profile amongst commercial and financial audiences in Europe. It will also enable European investors to trade Amarin shares on an open...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly